Institut Pasteur Korea reported a potent antiviral efficacy of nafamostat against SARS-CoV-2

COVID-19 treatment: update on current research with the Institut Pasteur in Korea and Philippe Le...

Institut Pasteur Korea and Daewoong Holdings are in preparation of clinical trial of niclosamide...

Clinical trial on ‘Alvesco’ will be initiated in Korea, for which Institut Pasteur Korea has conf...

Institut Pasteur Korea confirmed antiviral efficacy of “Alvesco”, a medicine for asthma, against...

Institut Pasteur Korea Developed Innovative Anticancer Drug Candidate that Reduces the Risk of Li...